Europe Cancer Vaccines Market Report 2016

October 2016 | 129 pages | ID: E159128D0EFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cancer Vaccines

Revenue, means the sales value of Cancer Vaccines

This report studies sales (consumption) of Cancer Vaccines in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Dendreon
• GlaxoSmithKline
• Merck
• Sanofi
• Vaccinogen
• Vaxon Biotech
• Vical
• Aduro BioTech
• Advantagene
• Advaxis
• Agenus
• AlphaVax
• Altor BioScience
• Amgen
• Antigen Express
• Argos Therapeutics
• Biothera
• Bristol-Myers Squibb
• Celldex Therapeutics

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Cancer Vaccines in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Cancer Vaccines in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Cancer Vaccines Market Report 2016

1 CANCER VACCINES OVERVIEW

1.1 Product Overview and Scope of Cancer Vaccines
1.2 Classification of Cancer Vaccines
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Cancer Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Cancer Vaccines Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Cancer Vaccines (2011-2021)
  1.5.1 Europe Cancer Vaccines Sales and Growth Rate (2011-2021)
  1.5.2 Europe Cancer Vaccines Revenue and Growth Rate (2011-2021)

2 EUROPE CANCER VACCINES BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Cancer Vaccines Market Competition by Manufacturers
  2.1.1 Europe Cancer Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Cancer Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Cancer Vaccines (Volume and Value) by Type
  2.2.1 Europe Cancer Vaccines Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Cancer Vaccines Revenue and Market Share by Type (2011-2016)
2.3 Europe Cancer Vaccines (Volume and Value) by Countries
  2.3.1 Europe Cancer Vaccines Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Cancer Vaccines Revenue and Market Share by Countries (2011-2016)
2.4 Europe Cancer Vaccines (Volume) by Application

3 GERMANY CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Cancer Vaccines Sales and Value (2011-2016)
  3.1.1 Germany Cancer Vaccines Sales and Growth Rate (2011-2016)
  3.1.2 Germany Cancer Vaccines Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Cancer Vaccines Sales Price Trend (2011-2016)
3.2 Germany Cancer Vaccines Sales and Market Share by Manufacturers
3.3 Germany Cancer Vaccines Sales and Market Share by Type
3.4 Germany Cancer Vaccines Sales and Market Share by Application

4 FRANCE CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 France Cancer Vaccines Sales and Value (2011-2016)
  4.1.1 France Cancer Vaccines Sales and Growth Rate (2011-2016)
  4.1.2 France Cancer Vaccines Revenue and Growth Rate (2011-2016)
  4.1.4 France Cancer Vaccines Sales Price Trend (2011-2016)
4.2 France Cancer Vaccines Sales and Market Share by Manufacturers
4.3 France Cancer Vaccines Sales and Market Share by Type
4.4 France Cancer Vaccines Sales and Market Share by Application

5 UK CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 UK Cancer Vaccines Sales and Value (2011-2016)
  5.1.1 UK Cancer Vaccines Sales and Growth Rate (2011-2016)
  5.1.2 UK Cancer Vaccines Revenue and Growth Rate (2011-2016)
  5.1.5 UK Cancer Vaccines Sales Price Trend (2011-2016)
5.2 UK Cancer Vaccines Sales and Market Share by Manufacturers
5.3 UK Cancer Vaccines Sales and Market Share by Type
5.4 UK Cancer Vaccines Sales and Market Share by Application

6 RUSSIA CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Cancer Vaccines Sales and Value (2011-2016)
  6.1.1 Russia Cancer Vaccines Sales and Growth Rate (2011-2016)
  6.1.2 Russia Cancer Vaccines Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Cancer Vaccines Sales Price Trend (2011-2016)
6.2 Russia Cancer Vaccines Sales and Market Share by Manufacturers
6.3 Russia Cancer Vaccines Sales and Market Share by Type
6.4 Russia Cancer Vaccines Sales and Market Share by Application

7 ITALY CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Cancer Vaccines Sales and Value (2011-2016)
  7.1.1 Italy Cancer Vaccines Sales and Growth Rate (2011-2016)
  7.1.2 Italy Cancer Vaccines Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Cancer Vaccines Sales Price Trend (2011-2016)
7.2 Italy Cancer Vaccines Sales and Market Share by Manufacturers
7.3 Italy Cancer Vaccines Sales and Market Share by Type
7.4 Italy Cancer Vaccines Sales and Market Share by Application

8 SPAIN CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Cancer Vaccines Sales and Value (2011-2016)
  8.1.1 Spain Cancer Vaccines Sales and Growth Rate (2011-2016)
  8.1.2 Spain Cancer Vaccines Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Cancer Vaccines Sales Price Trend (2011-2016)
8.2 Spain Cancer Vaccines Sales and Market Share by Manufacturers
8.3 Spain Cancer Vaccines Sales and Market Share by Type
8.4 Spain Cancer Vaccines Sales and Market Share by Application

9 BENELUX CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Cancer Vaccines Sales and Value (2011-2016)
  9.1.1 Benelux Cancer Vaccines Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Cancer Vaccines Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Cancer Vaccines Sales Price Trend (2011-2016)
9.2 Benelux Cancer Vaccines Sales and Market Share by Manufacturers
9.3 Benelux Cancer Vaccines Sales and Market Share by Type
9.4 Benelux Cancer Vaccines Sales and Market Share by Application

10 EUROPE CANCER VACCINES MANUFACTURERS ANALYSIS

10.1 Dendreon
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Cancer Vaccines Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Cancer Vaccines Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Merck
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Cancer Vaccines Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Sanofi
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Cancer Vaccines Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Vaccinogen
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Cancer Vaccines Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Vaccinogen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Vaxon Biotech
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Cancer Vaccines Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Vaxon Biotech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Vical
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Cancer Vaccines Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Vical Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Aduro BioTech
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Cancer Vaccines Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Aduro BioTech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Advantagene
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Cancer Vaccines Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Advantagene Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Advaxis
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Cancer Vaccines Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Advaxis Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Agenus
10.12 AlphaVax
10.13 Altor BioScience
10.14 Amgen
10.15 Antigen Express
10.16 Argos Therapeutics
10.17 Biothera
10.18 Bristol-Myers Squibb
10.19 Celldex Therapeutics

11 CANCER VACCINES MANUFACTURING COST ANALYSIS

11.1 Cancer Vaccines Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Vaccines

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Cancer Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE CANCER VACCINES MARKET FORECAST (2016-2021)

14.1 Germany Cancer Vaccines Sales Forecast (2016-2021)
14.2 France Cancer Vaccines Sales Forecast (2016-2021)
14.3 UK Cancer Vaccines Sales Forecast (2016-2021)
14.4 Russia Cancer Vaccines Sales Forecast (2016-2021)
14.5 Italy Cancer Vaccines Sales Forecast (2016-2021)
14.6 Spain Cancer Vaccines Sales Forecast (2016-2021)
14.7 Benelux Cancer Vaccines Sales Forecast (2016-2021)
14.8 Europe Cancer Vaccines Sales Forecast by Type (2016-2021)
14.9 Europe Cancer Vaccines Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Vaccines
Table Classification of Cancer Vaccines
Figure Europe Sales Market Share of Cancer Vaccines by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Cancer Vaccines
Figure Europe Sales Market Share of Cancer Vaccines by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure France Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure UK Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Russia Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Italy Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Spain Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Benelux Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure Europe Cancer Vaccines Revenue and Growth Rate (2011-2021)
Table Europe Cancer Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Cancer Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Vaccines Sales Share by Manufacturers
Figure 2016 Cancer Vaccines Sales Share by Manufacturers
Table Europe Cancer Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Cancer Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cancer Vaccines Revenue Share by Manufacturers
Table 2016 Europe Cancer Vaccines Revenue Share by Manufacturers
Table Europe Cancer Vaccines Sales and Market Share by Type (2011-2016)
Table Europe Cancer Vaccines Sales Share by Type (2011-2016)
Figure Sales Market Share of Cancer Vaccines by Type (2011-2016)
Figure Europe Cancer Vaccines Sales Growth Rate by Type (2011-2016)
Table Europe Cancer Vaccines Revenue and Market Share by Type (2011-2016)
Table Europe Cancer Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Vaccines by Type (2011-2016)
Figure Europe Cancer Vaccines Revenue Growth Rate by Type (2011-2016)
Table Europe Cancer Vaccines Sales and Market Share by Countries (2011-2016)
Table Europe Cancer Vaccines Sales Share by Countries (2011-2016)
Figure Sales Market Share of Cancer Vaccines by Countries (2011-2016)
Table Europe Cancer Vaccines Revenue and Market Share by Countries (2011-2016)
Table Europe Cancer Vaccines Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Cancer Vaccines by Countries (2011-2016)
Table Europe Cancer Vaccines Sales and Market Share by Application (2011-2016)
Table Europe Cancer Vaccines Sales Share by Application (2011-2016)
Figure Sales Market Share of Cancer Vaccines by Application (2011-2016)
Figure Germany Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure Germany Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure Germany Cancer Vaccines Sales Price Trend (2011-2016)
Table Germany Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Cancer Vaccines Sales by Type (2015 and 2016)
Table Germany Cancer Vaccines Market Share by Type (2015 and 2016)
Table Germany Cancer Vaccines Sales by Application (2015 and 2016)
Table Germany Cancer Vaccines Market Share by Application (2015 and 2016)
Figure France Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure France Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure France Cancer Vaccines Sales Price Trend (2011-2016)
Table France Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table France Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Cancer Vaccines Sales by Type (2015 and 2016)
Table France Cancer Vaccines Market Share by Type (2015 and 2016)
Table France Cancer Vaccines Sales by Application (2015 and 2016)
Table France Cancer Vaccines Market Share by Application (2015 and 2016)
Figure UK Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure UK Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure UK Cancer Vaccines Sales Price Trend (2011-2016)
Table UK Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Cancer Vaccines Sales by Type (2015 and 2016)
Table UK Cancer Vaccines Market Share by Type (2015 and 2016)
Table UK Cancer Vaccines Sales by Application (2015 and 2016)
Table UK Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Russia Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure Russia Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure Russia Cancer Vaccines Sales Price Trend (2011-2016)
Table Russia Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Cancer Vaccines Sales by Type (2015 and 2016)
Table Russia Cancer Vaccines Market Share by Type (2015 and 2016)
Table Russia Cancer Vaccines Sales by Application (2015 and 2016)
Table Russia Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Italy Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure Italy Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure Italy Cancer Vaccines Sales Price Trend (2011-2016)
Table Italy Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Cancer Vaccines Sales by Type (2015 and 2016)
Table Italy Cancer Vaccines Market Share by Type (2015 and 2016)
Table Italy Cancer Vaccines Sales by Application (2015 and 2016)
Table Italy Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Spain Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure Spain Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure Spain Cancer Vaccines Sales Price Trend (2011-2016)
Table Spain Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Cancer Vaccines Sales by Type (2015 and 2016)
Table Spain Cancer Vaccines Market Share by Type (2015 and 2016)
Table Spain Cancer Vaccines Sales by Application (2015 and 2016)
Table Spain Cancer Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Cancer Vaccines Sales and Growth Rate (2011-2016)
Figure Benelux Cancer Vaccines Revenue and Growth Rate (2011-2016)
Figure Benelux Cancer Vaccines Sales Price Trend (2011-2016)
Table Benelux Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Cancer Vaccines Sales by Type (2015 and 2016)
Table Benelux Cancer Vaccines Market Share by Type (2015 and 2016)
Table Benelux Cancer Vaccines Sales by Application (2015 and 2016)
Table Benelux Cancer Vaccines Market Share by Application (2015 and 2016)
Table Cancer Vaccines Basic Information List
Table Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Cancer Vaccines Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Cancer Vaccines Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Cancer Vaccines Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Cancer Vaccines Sales Market Share (2011-2016)
Table Vaccinogen Basic Information List
Table Vaccinogen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaccinogen Cancer Vaccines Sales Market Share (2011-2016)
Table Vaxon Biotech Basic Information List
Table Vaxon Biotech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaxon Biotech Cancer Vaccines Sales Market Share (2011-2016)
Table Vical Basic Information List
Table Vical Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical Cancer Vaccines Sales Market Share (2011-2016)
Table Aduro BioTech Basic Information List
Table Aduro BioTech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aduro BioTech Cancer Vaccines Sales Market Share (2011-2016)
Table Advantagene Basic Information List
Table Advantagene Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advantagene Cancer Vaccines Sales Market Share (2011-2016)
Table Advaxis Basic Information List
Table Advaxis Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advaxis Cancer Vaccines Sales Market Share (2011-2016)
Table Agenus Basic Information List
Table Agenus Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agenus Cancer Vaccines Sales Market Share (2011-2016)
Table AlphaVax Basic Information List
Table AlphaVax Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table AlphaVax Cancer Vaccines Sales Market Share (2011-2016)
Table Altor BioScience Basic Information List
Table Altor BioScience Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Altor BioScience Cancer Vaccines Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Cancer Vaccines Sales Market Share (2011-2016)
Table Antigen Express Basic Information List
Table Antigen Express Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Antigen Express Cancer Vaccines Sales Market Share (2011-2016)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Argos Therapeutics Cancer Vaccines Sales Market Share (2011-2016)
Table Biothera Basic Information List
Table Biothera Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biothera Cancer Vaccines Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Cancer Vaccines Sales Market Share (2011-2016)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celldex Therapeutics Cancer Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Vaccines
Figure Manufacturing Process Analysis of Cancer Vaccines
Figure Cancer Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2015
Table Major Buyers of Cancer Vaccines
Table Distributors/Traders List
Figure Germany Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Germany Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure France Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure France Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure UK Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure UK Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Europe Cancer Vaccines Sales Forecast by Type (2016-2021)
Table Europe Cancer Vaccines Sales Forecast by Application (2016-2021)